Frontlight ResearchEarly access
Kidney cancer trials in China
92 of 117 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy
- Where
- Nanjing
- Age
- 18 years to 80 years
- People
- 35
- Run by
- Jinling Hospital, China
See details and how to joinNCT06255223 - Early phase 1Taking people68Ga- and 18F-CAIX PET Imaging Study
- Where
- Beijing
- Age
- 18 years and over
- People
- 100
- Run by
- Peking University First Hospital
See details and how to joinNCT07875946 - Phase 1/2Not yet taking people in ChinaPhase Ib/II Clinical Study of QLS5133 Combination Therapy in Advanced Solid Tumors
- Where
- Jinan
- Age
- 18 years and over
- People
- 558
- Run by
- Qilu Pharmaceutical Co., Ltd.
See details and how to joinNCT07933419 - Phase 2Taking peopleA Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma
- Where
- Shanghai
- Age
- 18 years and over
- People
- 30
- Run by
- Imbioray (Hangzhou) Biomedicine Co., Ltd.
See details and how to joinNCT07087158 - Phase 2Taking peopleProspective Study of Cadonilimab With Lenvatinib in Renal Cell Carcinoma
- Where
- Beijing
- Age
- 18 years and over
- People
- 54
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07909265 - Phase 1/2Not yet taking people in ChinaA Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- Where
- Beijing, Changsha Shi, Guangzhou, Harbin, Nanjing, Shanghai Shi, Tianjin
- Age
- 18 years and over
- People
- 474 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07293351 · EU 2026-527163-15-00 - Phase 2Taking peopleAn Exploratory Study on the Failure of Immunotherapy With Vorolanib Combined With Everolimus
- Where
- Guangzhou, Zhengzhou
- Age
- 18 years and over
- People
- 80
- Run by
- Sun Yat-sen University
See details and how to joinNCT06730672 - No phaseTaking peopleEffect of Non-Clamping and Sutureless Technique on Postoperative Renal Function in Robot-Assisted Partial Nephrectomy
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 304
- Run by
- Shao Pengfei
See details and how to joinNCT07888608 - Phase 2Not yet taking people in ChinaA Clinical Study of Ivonescimab in Combination With Cadonilimab or Ipilimumab for Advanced Renal Cancer
- Where
- Beijing
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Summit Therapeutics
See details and how to joinNCT07877194 - Phase 2Taking peoplePerioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 162
- Run by
- Jinling Hospital, China
See details and how to joinNCT07672860 - No phaseTaking people18F-N230A PET/CT Imaging of Nectin-4 Expression in Renal Tumors
- Where
- Beijing
- Age
- 18 years and over
- People
- 80
- Run by
- Peking University First Hospital
See details and how to joinNCT07875959 - Phase 1Taking peopleClinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer(FASTIL-Renal01)
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 15
- Run by
- Hangzhou Huasai Biomedicine Co., Ltd.
See details and how to joinNCT07770802 - No phaseTaking peopleCAIX-targeted PET/CT in Solid Tumors
- Where
- Wuhan
- Age
- 18 years and over
- People
- 100
- Run by
- Zhongnan Hospital
See details and how to joinNCT07833085 - Phase 1/2Taking peopleSymbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Where
- Beijing, Changsha, Chongqing, Jinan, Nanjing, Ningbo, Wuhan
- Age
- 18 years and over
- People
- 224 worldwide
- Run by
- Pfizer
See details and how to joinNCT07227415 · EU 2025-523524-53-00 - Early phase 1Not yet taking people in ChinaA Study of CA9-Targeted CAR Macrophage Therapy in Advanced Clear Cell Renal Cell Carcinoma
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 6
- Run by
- Liangyou Gu
See details and how to joinNCT07865832 - Phase 2Not yet taking people in ChinaSBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma
- Where
- Fuzhou
- Age
- 18 years to 80 years
- People
- 27
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT07470840 - No phaseTaking peopleQLESP Block for Pain Control in Robotic Partial Nephrectomy
- Where
- Wuhan
- Age
- 18 years to 80 years
- People
- 120
- Run by
- Huazhong University of Science and Technology
See details and how to joinNCT07704970 - Phase 1Taking peopleA First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
- Where
- Jinan
- Age
- 18 years to 75 years
- People
- 299 worldwide
- Run by
- Huahui Health
See details and how to joinNCT07623369 - Phase 1Taking peopleA Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
- Where
- Beijing, Changsha, Guangzhou, Jinan, Jining, Shanghai, Shenyang, Shijiazhuang
- Age
- 18 years and over
- People
- 738 worldwide
- Run by
- NextCure, Inc.
See details and how to joinNCT06792552 - Phase 1/2Taking peoplePhase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 92
- Run by
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07239596 - Phase 2Taking peopleCD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk
- Where
- Nanjing, Wuxi
- Age
- 18 years and over
- People
- 75
- Run by
- Jinling Hospital, China
See details and how to joinNCT07615348 - Phase 2Taking peopleSABR Combined With Axitinib and Toripalimab for Oligometastatic Renal Cell Carcinoma
- Where
- Shijiazhuang
- Age
- 18 years and over
- People
- 48
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT07744932 - Phase 2Not yet taking people in ChinaGut Microbiota Modulation for Immunotherapy Resensitization in Advanced Renal Cell Carcinoma
- Where
- Nanjing
- Age
- 18 years to 90 years
- People
- 33
- Run by
- Jinling Hospital, China
See details and how to joinNCT07611825 - Phase 2Not yet taking people in ChinaA Prospective, Single-Arm, Multicenter Clinical Study of High-Risk Localized and Locally Advanced Renal Clear Cell Carcinoma
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 54
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07741617 - Phase 2Not yet taking people in ChinaIpilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial
- Where
- Chengdu
- Age
- 14 years and over
- People
- 66
- Run by
- West China Hospital
See details and how to joinNCT07715565